Furthermore, it is not yet known whether altered HNRNPK expression, or solely the loss of its function due to sequestration or mislocalization, is involved in the pathogenesis of C9 ALS/FTD. The gene discussed is HNRNPK; the disease is amyotrophic lateral sclerosis.